Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-23T17:12:28.422Z Has data issue: false hasContentIssue false

Elimination of arrhythmogenesis after subtotal resection of congenital cardiac fibroma: a case report

Part of: Surgery

Published online by Cambridge University Press:  30 October 2018

Taisuke Nabeshima*
Affiliation:
Department of Pediatric Cardiology, Okinawa Nambu and Children’s Medical Center, Okinawa, Japan Department of Pediatric Cardiology, Fukuoka Children’s Hospital, Fukuoka, Japan
Seiichi Sato
Affiliation:
Department of Pediatric Cardiology, Okinawa Nambu and Children’s Medical Center, Okinawa, Japan
Mami Nakayashiro
Affiliation:
Department of Pediatric Cardiology, Okinawa Nambu and Children’s Medical Center, Okinawa, Japan
*
Author for correspondence: T. Nabeshima, MD, Department of Pediatric Cardiology, Fukuoka Children’s Hospital, 5-1-1 Kashiiteriha, Higashi-ku, Fukuoka 813-0017, Japan. Tel: +81 92-682-7000; Fax: +81 92-682-7300; E-mail: [email protected]

Abstract

Subtotal tumour resection is used to treat infants with congenital cardiac fibroma and medication-resistant ventricular arrhythmias; however, complete elimination of arrhythmogenic substrates has been unclear. A 4-month-old male infant with congenital cardiac fibroma and ventricular fibrillation underwent subtotal tumour resection and implantable cardioverter-defibrillator implantation. Five years later, angiography revealed impending compression of the left coronary artery. Elimination of the arrhythmogenic substrate was confirmed and the device was removed successfully.

Type
Brief Report
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Nabeshima T, Sato S, Nakayashiro M. (2018) Elimination of arrhythmogenesis after subtotal resection of congenital cardiac fibroma: a case report. Cardiology in the Young29: 90–92. doi: 10.1017/S1047951118001750

References

1. Marx, GR, Moran, AM. Cardiac tumors. In Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, (eds) Moss & Adams Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult 8th edn. Lippincott Williams & Wilkins, Philadelphia, 2013; 1549–1555.Google Scholar
2. Padalino, MA, Vida, VL, Boccuzzo, G, et al. Surgery for primary cardiac tumors in children: early and late results in a multicenter European Congenital Heart Surgeons Association study. Circulation 2012; 126: 2230.Google Scholar
3. Miyake, CY, Del Nido, PJ, Alexander, ME, et al. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol 2011; 58: 19031909.Google Scholar
4. Sakamoto, S, Shibata, M, Murata, H, et al. Intraoperative cardiac mapping in the treatment of an infant congenital fibroma. Ann Thorac Surg 2015; 99: 10641066.Google Scholar
5. Orini, M, Nanda, A, Yates, M, et al. Mechano-electric feedback in the clinical setting: current perspectives. Prog Biophys Mol Biol 2017; 130: 365375.Google Scholar
6. Suzuki, S, Motohashi, S, Matsumoto, M, et al. Surgical techniques for implanting implantable cardioverter defibrillators in children and infants. Surg Today 2014; 44: 18011806.Google Scholar

Nabeshima et al. supplementary material

Nabeshima et al. supplementary material 1

Download Nabeshima et al. supplementary material(Video)
Video 23.5 MB

Nabeshima et al. supplementary material

Nabeshima et al. supplementary material 2

Download Nabeshima et al. supplementary material(Video)
Video 16 MB